Weight-loss medications are becoming valuable adjuncts in obesity management, offering clinicians additional tools for patients who show limited response to lifestyle modification. GLP-1 receptor agonists, in particular, demonstrate robust and durable weight reduction with notable metabolic benefits. However, in India, issues such as affordability, insurance coverage gaps, and uneven availability continue to limit their widespread adoption in routine practice. To understand how beneficial weight-loss drugs truly are for the Indian population, join eminent Community Medicine specialist Dr.
Amitav Banerjee in our 12 th anniversary special webinar on December 3 , 2025 , at 3:00 PM IST . Stay tuned! ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about the…
